Analyst On Endologix: No Sense In Downgrading Now
May 18, 2017 at 10:45 AM EDT
Endologix, Inc. (NASDAQ: ELGX) announced on Thursday after the market close that it needs to conduct a confirmatory clinical trial for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.